▶ We keep sharing the experience “MIL Train More MIL – SOLACI”, our program on structural heart disease for Latin American Women Interventionists 🩺 Our scholarship program on structural heart disease continues to thrive in specialized centers in Argentina. 🏥 Today was Favaloro Foundation’s turn. ▶ Here is the complete scientific program of day 4...
▶ We continue to share the experience “MIL Training More MIL – SOLACI”, our training program on structural heart disease for Latin American Women Interventionists. 👉 The third day of activities was carried out at the Italian Hospital in Buenos Aires. ✅ We had an inspiring scientific agenda: 👉 20 years of TAVR, where our...
▶ The intensive in-person training on structural heart disease for Latin American Women Interventionists selected for MIL Training More MIL continues. 👉 The second day of activities was carried out at Hospital Finochietto. ✅ The following activities took place today: 👉 Case presentation with Acurate Neo2, by Dr. Maximiliano Jara.👉 Hospital Case👉 Dissertation on “Echo...
▶ The first group of interventionists women who were granted a scholarship structural heart disease has started at the Cardiovascular Institute of Buenos Aires (ICBA). The program will be held during the week in different centers across Argentina. ✅ The event featured self-expanding and balloon expandable TAVR cases and transcatheter closure of periprosthetic leak. Moreover, complex...
The presence of aortic stenosis, heart failure, and decreased ventricular function is associated with poor prognosis and high mortality. For this reason, both European and American guidelines classify severe stenosis as a Class I indication. There are two retrospective analyses that demonstrate the benefits of transcatheter aortic valve implantation (TAVI) via transfemoral access. The TAVR...
Despite major advances in secondary prevention and reperfusion strategies, acute myocardial infarction (AMI) still causes morbidity and mortality. A significant portion of acute events arise from mild to moderate lesions identified months to years before the index event. Early detection of lesions at higher risk of progression and rupture may allow for more targeted treatment...
Abbreviated dual antiplatelet therapy in patients at high risk for bleeding and acute myocardial infarction. Patients with acute coronary syndrome (ACS) who undergo stent placement (percutaneous coronary intervention, PCI) conventionally require at least 12 months of dual antiplatelet therapy (DAPT) to reduce ischemic events. Patients with ACS who are also at high risk for bleeding...
In last few years, transcatheter edge-to-edge repair (TEER) with MitraClip has been shown safe and effective, both for primary and secondary mitral valve regurgitation (MR), given the increasing interventionist and echocardiographer experience. However, there is a group of patients that require surgery after failed TEER, either because of bad evolution or because device implantation...
The optimal treatment of true bifurcation lesions not affecting the left main coronary artery is widely debated. Results from randomized studies have shown neutral or worse outcomes with the two-stent technique. Regarding these studies, researchers used first-generation stents and the secondary branches were small. The EBC TWO study compared the provisional stenting strategy against the...
The ACURATE Neo2 valve is an evolution of the first-generation ACURATE Neo valve with a low rate of pacemaker implantation and a decrease in paravalvular leak, also compatible with the 14F introducer. This prospective study included patients with symptomatic severe aortic stenosis at high surgical risk who underwent ACURATE Neo2 valve implantation. The primary endpoint...